Actively Recruiting
Speech Treatment for Minimally Verbal Children With ASD and CAS
Led by MGH Institute of Health Professions · Updated on 2026-03-30
20
Participants Needed
1
Research Sites
343 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Comorbid Childhood Apraxia of Speech (CAS) may be one factor that limits speech development in some minimally verbal children with autism. CAS is a disorder affecting speech movement planning. This study tests whether CAS-specific treatment, appropriately modified for minimally verbal children with autism, improves their speech.
CONDITIONS
Official Title
Speech Treatment for Minimally Verbal Children With ASD and CAS
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Meets criteria for Autism Spectrum Disorder
- Able to correctly repeat at least 2 syllables
- Meets criteria for Childhood Apraxia of Speech
- Lives in an environment where child is exposed to English at least 50% of the time
You will not qualify if you...
- Poorly controlled seizures
- Factors such as blindness or deafness that contribute to minimally verbal status
- Lives in an environment where English is not spoken at least 50% of the time
- Child experiences behavioral challenges that preclude participation in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
MGH Institute of Health Professions
Boston, Massachusetts, United States, 02129
Actively Recruiting
Research Team
K
Karen V Chenausky, Ph.D.
CONTACT
M
Michael Moody
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here